Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Gauging the Upsides and downsides of Visas: A Complete Aide - 2Figure out How to Adjust Work, Life, and an Internet based Degree
- 3$30K Disability Scam Implodes After Surf Trip in Mexico
- 4Flourishing as a Charitable Pioneer: Individual Encounters in Generosity
- 5Amateur's Manual for Venture Strategies for Tenderfoots
- The most effective method to Connect Successfully with Teachers in a Web based Setting
- The Response to Independence from the rat race: Methodologies for Creating Financial momentum
- Understanding Various Sorts of Financial balances: An Extensive Outline
- The Longest Underwater Tunnel Connecting Germany and Denmark
- Fears of global aluminum shortages intensify
- Lebanon’s Hezbollah and Yemen’s Houthis join Iran in strike on Israel
- Surveys of Music Collections by Film Stars
- Artemis 2 astronauts see Earth in the rear-view mirror | Space photo of the day for April 3, 2026
- Figure out How to Amplify the Resale Worth of Your Kona SUV
